Clinical Research on Electromagnetic Field Modulation

The Aires research program spans 33 years of independent scientific investigation. A significant portion of that program involved human clinical and quasi-clinical studies — research conducted with human subjects in controlled conditions, measuring objective biological endpoints rather than self-reported outcomes.

This page summarizes the human research record: the institutions involved, the measurement endpoints used, and what the studies found.

EEG Research Program (Brain Electrical Activity)

The largest body of human research in the Aires program focuses on electroencephalography (EEG) — objective, quantitative measurement of brain electrical activity. EEG is not a self-report tool; it measures real-time voltage patterns at the scalp, producing quantitative data independent of subject expectation.

The research question across all EEG studies was consistent: does mobile phone or computer EMF measurably alter brain wave patterns, and does the presence of the Aires device attenuate that alteration?

Pavlov Institute of Physiology, Russian Academy of Sciences

Five EEG studies between 2000 and 2005, authored by Rybina, Shuvayev, and Sysoev. Subjects were exposed to mobile phone EMF during defined protocol periods with and without the Aires device. Findings: mobile phone EMF produced measurable changes in alpha and theta wave patterns. With the Aires device present, these perturbations were consistently attenuated. Alpha waves (8–12 Hz) regulate alert relaxation and attention; theta waves (4–8 Hz) regulate memory consolidation and sleep transition.

S.M. Kirov Military Medical Academy

Research on central nervous system function during extended computer work. EMF from computer equipment produced measurable CNS parameter changes. The presence of the Aires device modified these responses.

North-Western State Medical University

Additional EEG research documenting consistent directional findings across a separate subject population.

Cardiovascular Research

Djanelidze Research Institute of Emergency Medicine

Clinical research with ischemic heart disease patients — a population with elevated cardiovascular sensitivity. Studies documented heart rate and autonomic nervous system responses to EMF exposure, with consistent directional findings in the presence of the Aires device.

Hypertension Clinic Research

Sympathetic nervous system responses in hypertensive subjects. This population was selected specifically because elevated sympathetic tone (the stress-response arm of the autonomic nervous system) amplifies observable cardiovascular responses, providing higher sensitivity to field-mediated effects.

Dr. Magda Havas — Trent University, Canada (2015)

The most methodologically rigorous cardiovascular study in the corpus. Dr. Havas conducted a double-blind, placebo-controlled case study using FDA Class II cardiac monitoring equipment. Her subjects were exposed to Wi-Fi electromagnetic fields; the endpoint was heart rate variability (HRV) — a quantitative autonomic nervous system marker.

The study was n=2. That limits its statistical power, but the design is exemplary: double-blind (neither subject nor experimenter knew which condition was active), placebo-controlled (sham device as control), clinical-grade measurement equipment, independent researcher with no prior relationship with Aires. Findings: Wi-Fi EMF produced measurable HRV disruption; Aires device presence attenuated the disruption. Dr. Havas independently characterized this study and the 2019 Dyuzhikova program as representing excellent research design.

Blood and Immune Parameter Research

2025 Blood Study — Pavlov Institute of Physiology

The most recent and scientifically significant human study in the research program. A double-blind controlled study with 30 subjects measured blood parameters before and after exposure to a Wi-Fi 6 router operating at 6 GHz — a next-generation frequency deployed in Wi-Fi 6 and early 5G infrastructure.

Two findings of note:

1. Statistically significant immune parameter changes — specific blood markers shifted measurably under Wi-Fi 6 exposure. With the Aires device present, these changes were substantially reduced.

2. First genotype-dependent EMF response documented in scientific literature — individual genetic profile predicted the magnitude of blood parameter response to EMF exposure. This is a scientifically significant finding because it provides a mechanistic explanation for observed variability in human EMF sensitivity: it is not psychosomatic variation but genetic variation in physiological response pathways.

Research on Specific Populations

Pediatric and Developmental Research

Some studies in the program addressed EMF effects and device performance in pediatric contexts, motivated by the biological reality that developing nervous systems have different EMF sensitivity than adult systems. These studies are cataloged in the research archive.

Electromagnetic Hypersensitivity

Research on self-identified electromagnetically sensitive individuals, including symptom tracking and objective physiological measurement. This population is scientifically significant as a potential high-sensitivity detector of field effects.

DNA Integrity Research

RUDN University (Peoples' Friendship University of Russia)

Gene expression and DNA integrity studies documenting chromosomal effects under EMF exposure and modification of those effects in the presence of the Aires device. These studies complement the animal chromosomal aberration program at IFRAN (see animal model research) by providing human cell-line and peripheral blood lymphocyte data.

Research Design and Methodological Standards

Human research in the Aires program used several study designs:

Controlled crossover designs — subjects serve as their own controls, measured with and without EMF and/or device across defined protocol periods. Reduces between-subject variability.

Double-blind, placebo-controlled designs — used in the Havas HRV study and the 2025 blood study. Gold standard for eliminating expectation bias.

Objective endpoint measurement — all studies used quantitative measurement (EEG voltage patterns, HRV indices, blood marker assays, gene expression panels) rather than self-reported symptom scales.

Clinical populations — research in ischemic heart disease patients and hypertensives provides elevated sensitivity and translational relevance for the populations most affected by cardiovascular EMF responses.

Current Research Milestones

The next phase of the human research program is focused on three milestones:

Independent biological replication at a Western institution — replication of the EEG and HRV findings by a North American or European university with no prior relationship with Aires, under preregistered protocol.

Adequately powered human RCT — a randomized controlled trial with statistical power sufficient to provide definitive evidence at publication-quality standards, targeting the blood parameter and HRV endpoints where effect sizes are largest.

Genotype-stratified follow-up study — building on the 2025 blood study finding, a larger study stratifying subjects by genetic profile to characterize the dose-response relationship between genotype, EMF sensitivity, and device protective effect.

Further Reading

• 33-Year Research Program Overview
• EEG and Brain Activity Research (Full Program)
• IFRAN Longitudinal Animal Research Program
• Researcher Profiles — Named Scientists and Institutions
• Full Research Archive — 60+ Studies
• Does Aires Work? Complete Evidence Summary